Company / Capital Returned to Shareholders per Share
Biogen Capital Returned to Shareholders per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
-
FY2024
5-year range
$0.00 / $10.33
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#47 of 51
Health Care
What the data says
Declined from $4.92 to $0.00 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 51
▼
Key checks
Key Insights
- Peak capital returned to shareholders per share was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.00 | - |
| FY2023 | $0.00 | -100.0% |
| FY2022 | $4.92 | -52.4% |
| FY2021 | $10.33 | -69.5% |
| FY2020 | $33.87 | +22.1% |
| FY2019 | $27.75 | +37.6% |
| FY2018 | $20.16 | +218.8% |
| FY2017 | $6.32 | +38.2% |
| FY2016 | $4.57 | -78.5% |
As of FY2024 · SEC 10-K · Updated Mar 3, 2026